Brown Advisory’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Brown Advisory’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,000	Closed	-$6K	–	1322
2017 Q4	$6K	Buy	+13,000	New	+$32.3K	﹤0.01%	1219

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Brown Advisory's SGYP Position: Q1 2019 in Review

Brown Advisory sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 212,947 shares — an estimated $24K sold.

Brown Advisory first reported a position in SGYP in Q2 2017 and held it in 7 quarters. The position peaked at $458K in Q3 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Brown Advisory reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Brown Advisory sold 212,947 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $24K.
Brown Advisory first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2017 and held it in 7 quarters.
Brown Advisory's Synergy Pharmaceuticals, Inc Common Stock position peaked at $458K in Q3 2017.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Brown Advisory's 13F filing for Q1 2019, filed 15 May 2019.